European Heart Journal – Quality of Care and Clinical Outcomes (EHJ-QCCO) is an official Journal of the European Society of Cardiology. It accepts manuscripts from all parts of the world by members and non-members of the Society. The European Society of Cardiology may promote and make available to certain parties the finalised version of an article shortly prior to publication in the journal.
Papers that do not adhere to these instructions will be returned for revision before assessment.
Human or Animal Experimentation
Studies must comply with the Declaration of Helsinki and the locally appointed ethics committee must have approved the research protocol. Informed consent must be obtained from human subjects (or their legally authorized representative). These facts must be stated in the manuscript. Authors may be required to provide evidence that they obtained ethical and /or legal approval prior to conducting the research.
Where studies involving animals are reported, authors must follow the ARRIVE guidelines when preparing their manuscript. Authors must indicate the nature of the ethical review permissions, relevant licences, and national or institutional guidelines for the care and use of animals, that cover the research.
Conflict of Interest
European Heart Journal - Quality of Care and Clinical Outcomes follows the guidelines of the International Committee of Medical Journal Editors and an ICMJE disclosure of potential conflicts of interest form must be submitted for each author at the time of manuscript submission. Forms must be submitted even if there is no conflict of interest. It is the responsibility of the corresponding author to ensure that all authors adhere to this policy prior to submission. Submissions without accompanying forms will not be sent for peer review.
A conflict of interest statement must also be included in the manuscript after any "Acknowledgements" and "Funding" sections and should summarize all aspects of any conflicts of interest included on the ICMJE form. If there is no conflict of interest, authors must include 'Conflict of Interest: none declared' in their manuscript.
All original research papers submitted to EHJ-QCCO receive editorial review. Those with publication potential are sent out for external peer-review plus additional statistical review in most cases. These reviews are anonymised and fed back to the corresponding author. Authors may be asked to revise their submissions based on reviewers’ comments but it is the Editorial Committee that is responsible for the final decision to accept or reject a paper.
All papers for regular issues should be submitted online at www.editorialmanager.com/ehj-qcco. This will take you to the online submission and editorial system for European Heart Journal - Quality of Care and Clinical Outcomes. Please follow the instructions given on screen.
Please note that if you are submitting a paper following a 'Reject de novo' decision, please include a response to reviewer comments from the initial peer review with your new submission and a copy of the tracked version of the manuscript.
For any queries during the submission and peer review process please contact the editorial office at firstname.lastname@example.org
Manuscripts should be typed, double spaced using 2.5 cm wide margins all around. The text is arranged as follows: (1) introduction, (2) methods, (3) results, (4) discussion, (5) acknowledgements, (6) references. (Format may be altered for review articles, if necessary.)
The following are entered seperately within the online submission system: title page, abstract and keywords, appendices, text tables, figure legends.
Please supply the names of two referees to whom your manuscript may be sent for review.
The title page bears: (a) title, (b) name(s) of Author(s), (c) institution(s) where work was done, (d) all addresses of Authors and (e) with the Corresponding Author’s complete address, telephone number, and e-mail address.
An abstract (maximum 250 words) is typed double spaced. The abstract of an original research article is structured under the headings (1) aims, (2) methods and results, (3) conclusion.
Between 3 and 5 key words are required.
Units and Abbreviations
Abbreviations other than standard SI units of measurement are not used.
Place acknowledgements, including information on grants received, before the references, in a separate section, and not as a footnote on the title page.
All editorials should be between 1000 and 1500 words (including references, figure legends and tables), with a maximum of 5 references.
Original articles should not exceed 5000 words (excluding references, figure legends and tables) and a maximum of 50 references.
Authors are required to use the appropriate research reporting guidelines for the study type available through the EQUATOR Network.
Randomised controlled trials (RCTs): CONSORT guidelines
Observational studies using routinely collected health data: RECORD guidelines
Diagnostic accuracy studies: STARD guidelines
Quality improvement studies: SQUIRE guidelines
Authors are further encouraged to submit guideline checklists with their manuscripts.
Reviews should not exceed 5000 words (including references and the text in figure legends and tables). Only up to 50 references will be published; if more references are submitted, the reference list will be published online.
Letters in response to articles published in EHJQCC may include up to 1000 words, 2 figures/tables and 5 references. These should have no abstract and no sub-headings. Type double-spaced. Letters reporting original research findings may also be considered and should contain a short description of methods, results and conclusions is required. Letters reporting data obtained from research conducted in human subjects must include a statement of assurance that (1) informed consent was obtained from each patient and (2) the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution's human research committee. Letters reporting experiments using animals must include a statement giving assurance that all animals received humane care and that study protocols comply with the institution's guidelines.
Figures should be self-explanatory and contain as much information as is consistent with clarity. All figures must carry the figure number in Arabic numerals. Citation in the text should take the form Fig. 1a etc. The minimum resolution for the figures is 300 dpi (dots per inch) for tone or colour, 1200 dpi for line art at approximately the correct size for publication. A scale should be included; otherwise the scale of the original should be stated in the legends so that the final scale can be calculated. Colour figures should be CMYK (Cyan-Magenta-Yellow-Black).
For useful information on preparing your figures for publication, go to http://cpc.cadmus.com/da.
Please note that all labels used in figures should be in lower case in both the figure and the legend. The journal reserves the right to reduce the size of illustrative material. All micrographs must carry a magnification bar.
Line drawings should be clear: faint shading or stippling will be lost upon reproduction and should be avoided and heavy shading or stippling may appear black. Lines and symbols should be drawn boldly enough to stand reduction to the desired size. For graphs where reduction to one-half in linear dimensions is intended, a suitable thickness for the axis would be 0.3 mm and for the other lines 0.4 or 1.0 mm depending on the complexity of the graph.
The preferred symbols are closed circle, open circle, closed square, open square, closed triangle, and open triangle and should be no smaller than 2 mm (height/diameter
Photographs not supplied electronically, must be of high quality, printed on glossy paper and mounted neatly on a thin white card base, leaving a narrow gap between each print. Irregular and asymmetrically distributed groups of photographs will not be accepted. Individual figures should be lettered, a, b, c, etc. on the photograph using a lettering set. Other lettering, arrows, etc. may be put on the photograph by the author; otherwise they should be indicated in the exact position required on a transparent or translucent self-locating overlay. On no account should any marks be made on the photograph itself.
There are no charges for colour figures. Colour plates should be combined to make a single composite figure whenever possible.
A separate typewritten, double-spaced list of legends of all figures must be supplied and included in the text file. Each legend should contain sufficient explanation to be meaningful without cross-referencing. A scale of the original should be included in the legend unless already indicated in the picture. A description of the symbols used in the figures should be written out in full. (Please do not include the character symbol in the legend.)
Please be aware that figure legends may be used by search engines for figure searches.
Tables should be on a separate page, and should be numbered in Arabic numerals with an appropriate legend at the head, and explanatory notes below. They should be included in the text file (either in the .PDF file for first submissions or in the Word file for accepted manuscripts).
References are identified in the text by Arabic numerals and numbered in the order cited.
References are typed double spaced on pages separate from the text in the Vancouver style, e.g.:
Birnbaum Y, Sclarovsky S, Mager A, Strasberg B, Rechavia E, ST segment depression in aVL: a sensitive marker for acute inferior myocardial infarction. Eur Heart J 1993; 14: 4-7.
Personal communications, manuscripts in preparation and other unpublished data are not cited in the reference list but are mentioned in the text in parentheses.
Titles of journals should be abbreviated in accordance with Medline. Complete information should be given for each reference, including title of article, abbreviated journal title and inclusive pagination. Full author names are required for references.
Supplementary data may be submitted for online only publication if it adds value for potential readers. However, it must not contain material critical to the understanding of the manuscript. The hard copy of the manuscript should stand alone, but it should be indicated at an appropriate point in the text that supplementary material is available on-line. In addition, the availability of supplementary material should also be indicated in the manuscript by a section heading
‘Supplementary Data’ with a brief description of these data to appear before the Acknowledgements and References. Please name your supplementary material and cite it within the manuscript as Figure S1, Table S1, Video S1, etc, and provide a detailed legend.
Electronic files of supplementary material are preferable as one complete .PDF file. If images are supplied as .GIFs or .JPEGs, the minimum acceptable resolution for viewing on screen is 120 dpi.
Authors should carefully check the supplementary data as this information is not professionally copy edited or proofread.
The preferred formats for video clips are .MOV, .MPG, .AVI, and animated .GIF files. Authors are advised to use a readily available program to create movies so that they can be viewed easily with e.g., Windows Media Player or QuickTime.
Please note that if your manuscript includes any data in tables or figure(s) modified or re-drawn from another publication, you will need permission from the original publisher to reproduce it before your manuscript can be published. This includes figures adapted in any way from other publications. Permission to reproduce figures or data from other publications must be obtained by authors at the time of acceptance. Please note that obtaining copyright permission could take some time. A copy of the permission document should be sent to the Production Editor.
European Heart Journal – Quality of Care and Clinical Outcomes
Oxford University Press
Great Clarendon Street
To seek copyright permission please contact the copyright permission department of the relevant journal/publisher.
Third-Party Content in Open Access papers
If you will be publishing your paper under an Open Access licence but it contains material for which you do not have Open Access re-use permissions, please state this clearly by supplying the following credit line alongside the material:
Title of content
Author, Original publication, year of original publication, by permission of [rights holder]
This image/content is not covered by the terms of the Creative Commons licence of this publication. For permission to reuse, please contact the rights holder.
It is a condition of publication in the journal that authors grant an exclusive licence to the European Society for Cardiology (ESC). This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. In assigning the licence, authors may use their own material in other publications provided that the journal is acknowledged as the original place of publication, and Oxford University Press, on behalf of the European Society for Cardiology (ESC), is notified in writing and in advance.
Upon receipt of accepted manuscripts at Oxford Journals authors will be invited to complete an online copyright licence to publish form.
Please note that by submitting an article for publication you confirm that you are the corresponding/submitting author and that Oxford University Press ("OUP") may retain your email address for the purpose of communicating with you about the article. You agree to notify OUP immediately if your details change. If your article is accepted for publication OUP will contact you using the email address you have used in the registration process. Please note that OUP does not retain copies of rejected articles.
Authors may enter the accepted manuscript of their article in PubMedCentral, other subject repositories, or institutional repositories, but they must stipulate that public availability be delayed until 12 months after the first online publication in the journal. For further details on this policy, please visit: Author Self-archiving Policy
European Heart Journal - Quality of Care and Clinical Outcomes authors have the option to publish their paper under the Oxford Open initiative; whereby, for a charge, their paper will be made freely available online immediately upon publication. After your manuscript is accepted the corresponding author will be required to accept a mandatory licence to publish agreement. As part of the licensing process you will be asked to indicate whether or not you wish to pay for open access. If you do not select the open access option, your paper will be published with standard subscription-based access and you will not be charged.
Oxford Open articles are published under Creative Commons licences.
RCUK/Wellcome Trust funded authors publishing in European Heart Journal - Quality of Care and Clinical Outcomes can use the Creative Commons Attribution licence (CC-BY) for their articles.
All other authors may use the Creative Commons Attribution Non-Commercial licence (CC-BY-NC)
You can pay Open Access charges using our Author Services site. This will enable you to pay online with a credit/debit card, or request an invoice by email or post. The open access charges are as follows:
Content will be free to view under Standard Licence until the end of 2016 only so by paying for Open Access you are ensuring that your content will be freely accessible in perpetuity.
Charges for CC-BY-NC:
- Regular charge: £1,500 / $2,660 / €2,275
- Recuced Rate Developing country charge: £750 / $1,330 / €1,138
- Free Developing country charge: Free
Charges for CC-BY:
- Regular charge: £1730 / $2980 / €2600
- Reduced Rate Developing country charge: £865 / $1,490 / €1,300
- Free Developing country charge: Free
Discounted rates are available for authors based in some developing countries (click here for a list of qualifying countries).
Orders from the UK will be subject to a VAT charge. For orders from the rest of the European Union, OUP will assume that the service is provided for business purposes. Please provide a VAT number for yourself or your institution, and please ensure that your own local VAT is correctly accounted for.
Crossref Funding Data Registry
In order to meet your funding requirements authors are required to name their funding sources, or state if there are none, during the submission process. For further information on this process or to find out more about the CHORUS initiative please click here.
If English is not your first language, you may wish to use an English language editing service before submission. This may help to ensure that the academic content of your paper is fully understood by the journal editors and reviewers. Several specialist language editing companies offer this service and authors are liable for all costs associated. Further information.
Proofs will be sent electronically to the corresponding author as a .PDF file. The author should reply to the proof email with their corrections, and should send either a list of corrections in the email or attach an annotated PDF. Corrections should be limited to typographical errors and corrections should be returned within three days of receipt; otherwise the Editor reserves the right to correct the proofs and to send the material for publication. This is essential if all the material in a given issue is not to be delayed by the late receipt of one corrected proof.
A URL providing free access to the online version of the article will be e-mailed to the corresponding author. This link may then be distributed to interested parties. Paper offprints may be ordered at proof stage using the Offprint Order Form sent with the proof. Orders from the UK will be subject to the current UK VAT charge. For orders from elsewhere in the EU you or your institution should account for VAT by way of a reverse charge. Please provide us with your or your institution’s VAT number.